Roman Stauch – Trademark Portfolio

Entity Type: 01

Roman Stauch holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CYBION.

Rengershäuser Str. 38

97959 Assamstadt

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CYBION
CYBION
Registered 2021

Trademark Classifications

Roman Stauch's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Roman Stauch have?

Roman Stauch has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Roman Stauch file in?

Roman Stauch files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Roman Stauch's most well-known trademarks?

Roman Stauch's registered trademark portfolio includes well-known marks such as CYBION. These are among 1 currently registered trademark in the portfolio.

What is Roman Stauch's trademark registration success rate?

Roman Stauch has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.